Search results for "target"

showing 10 items of 1196 documents

Measurement of the parity violating asymmetry in the quasielastic electron-deuteron scattering and improved determination of the magnetic strange for…

2016

A new measurement of the parity-violating asymmetry in the electron-deuteron quasielastic scattering for backward angles at $⟨{Q}^{2}⟩=0.224\text{ }\text{ }{(\mathrm{GeV}/c)}^{2}$, obtained in the A4 experiment at the Mainz Microtron accelerator (MAMI) facility, is presented. The measured asymmetry is ${A}_{PV}^{d}=(\ensuremath{-}20.11\ifmmode\pm\else\textpm\fi{}0.8{7}_{\mathrm{stat}}\ifmmode\pm\else\textpm\fi{}\phantom{\rule{0ex}{0ex}}1.0{3}_{\mathrm{sys}})\ifmmode\times\else\texttimes\fi{}{10}^{\ensuremath{-}6}$. A combination of these data with the proton measurements of the parity-violating asymmetry in the A4 experiment yields a value for the effective isovector axial-vector form facto…

Particle physicsacceleratorparity: violation: asymmetrymedia_common.quotation_subjectLattice field theoryisovectorelectron deuteron: inelastic scatteringpolarized beamElectron[PHYS.NEXP]Physics [physics]/Nuclear Experiment [nucl-ex]form factor: axial-vector01 natural sciencesAsymmetryMainz Linac0103 physical sciencesdeuterium: targetradiative correctionelectron: beam010306 general physicsmedia_commonPhysicsQuasielastic scatteringIsovector010308 nuclear & particles physicsScatteringbackgroundlattice field theoryParity (physics)helicityanapoleHelicityelectron deuteron: scatteringexperimental results
researchProduct

Influence of the oncolytic parvovirus H-1, CTLA-4 antibody tremelimumab and cytostatic drugs on the human immune system in a human in vitro model of …

2013

Bernd Heinrich,* Katrin Goepfert,* Maike Delic, Peter R Galle, Markus MoehlerUniversity Medical Center of the Johannes Gutenberg University Mainz, 1st Department of Internal Medicine, Langenbeckstrasse, Mainz, Germany *These authors contributed equally to this workIntroduction: Tumor-directed and immune-system-stimulating therapies are of special interest in cancer treatment. Here, we demonstrate the potential of parvovirus H-1 (H-1PV) to efficiently kill colorectal cancer cells and induce immunogenicity of colorectal tumors by inducing maturation of dendritic cells (DCs) alone and also in combination with cytostatic drugs in vitro. Using our cell culture model, we have additionally investi…

Parvovirus H-1business.industrymedicine.medical_treatmentOncoTargets and TherapyOncolytic virusImmune systemCytokineOncologyAntigenCTLA-4ImmunologyCancer researchmedicineSW480Cytotoxic T cellPharmacology (medical)dendritic cellsbusinessTremelimumabmedicine.drugOriginal ResearchOncoTargets and Therapy
researchProduct

Automated Measurement of Microcirculatory Blood Flow Velocity in Pulmonary Metastases of Rats

2014

Because the lung is a major target organ of metastatic disease, animal models to study the physiology of pulmonary metastases are of great importance. However, very few methods exist to date to investigate lung metastases in a dynamic fashion at the microcirculatory level, due to the difficulty to access the lung with a microscope. Here, an intravital microscopy method is presented to functionally image and quantify the microcirculation of superficial pulmonary metastases in rats, using a closed-chest pulmonary window and automated analysis of blood flow velocity and direction. The utility of this method is demonstrated to measure increases in blood flow velocity in response to pharmacologi…

Pathologymedicine.medical_specialtyLung NeoplasmsIntravital MicroscopyGeneral Chemical EngineeringBreast NeoplasmsGeneral Biochemistry Genetics and Molecular BiologyMicrocirculationNeovascularizationRats NudeCell Line TumormedicineAnimalsHumansCancer BiologyLungNeovascularization PathologicGeneral Immunology and Microbiologybusiness.industryMicrocirculationGeneral NeuroscienceBlood flowmedicine.diseaseRatsmedicine.anatomical_structureHeterograftsFemaleSarcoma ExperimentalSarcomamedicine.symptombusinessPulmonary tumorBlood Flow VelocityTarget organIntravital microscopyJournal of Visualized Experiments
researchProduct

INFLAMMATION IN IRRITABLE BOWEL SYNDROME: MYTH OR NEW TREATMENT TARGET?

2016

Low-grade intestinal inflammation plays a key role in the pathophysiology of irritable bowel syndrome (IBS), and this role is likely to be multifactorial. The aim of this review was to summarize the evidence on the spectrum of mucosal inflammation in IBS, highlighting the relationship of this inflammation to the pathophysiology of IBS and its connection to clinical practice. We carried out a bibliographic search in Medline and the Cochrane Library for the period of January 1966 to December 2014, focusing on publications describing an interaction between inflammation and IBS. Several evidences demonstrate microscopic and molecular abnormalities in IBS patients. Understanding the mechanisms u…

Pathologymedicine.medical_specialtyMEDLINEAnti-Inflammatory AgentsInflammationCochrane LibraryBioinformaticsMast cell03 medical and health sciences0302 clinical medicineTreatment targetsGastrointestinal AgentsIntestinal inflammationmedicinePathologyAnimalsHumansMolecular Targeted TherapyTopic HighlightIntestinal MucosaIrritable bowel syndromeInflammationSettore MED/12 - GastroenterologiaMechanism (biology)business.industrySettore BIO/16 - Anatomia UmanaGastroenterologyGeneral MedicineInflammation; Irritable bowel syndrome; Mast cells; Neuroendocrine cells; Pathologymedicine.diseaseEnteritisClinical trialIrritable bowel syndromeSettore MED/18 - Chirurgia Generale030220 oncology & carcinogenesisNeuroendocrine cell030211 gastroenterology & hepatologymedicine.symptomInflammation Mediatorsbusiness
researchProduct

Therapeutic targets for overactive bladder other than smooth muscle

2015

For a long time, our concepts of regulation of urinary bladder function in health and disease as well as of the target structures of therapeutics have focused on detrusor smooth muscle cells. However, other structures including urothelium, afferent nerves and bladder blood vessels may also be important in pathophysiology and its treatment.Based on a selective review of literature, we discuss the role of urothelium, afferent nerve fibers and bladder blood vessels in bladder pathophysiology and as targets for treatment.There is solid evidence now that multiple anatomical structures within the urinary bladder contribute to the regulation of its function and hence may be targets for established…

Pathologymedicine.medical_specialtyMyocytes Smooth MuscleUrinary BladderClinical BiochemistryAnatomical structuresDiseaseurologic and male genital diseasesNerve FibersSmooth muscleAfferentDrug DiscoverymedicineAnimalsHumansMolecular Targeted TherapyUrotheliumPharmacologyAfferent PathwaysUrinary bladderUrinary Bladder Overactivebusiness.industrymedicine.diseasefemale genital diseases and pregnancy complicationsPathophysiologymedicine.anatomical_structureOveractive bladderDrug DesignMolecular MedicineUrotheliumbusinessNeuroscienceExpert Opinion on Therapeutic Targets
researchProduct

Discordance rate of HER2 status in primary breast carcinomas versus synchronous axillary lymph node metastases: a multicenter retrospective investiga…

2014

Antonio Ieni,1 Valeria Barresi,1 Rosario Caltabiano,2 Anna Maria Cascone,3 Rachele Del Sordo,4 Daniela Cabibi,5 Pio Zeppa,3 Salvatore Lanzafame,2 Angelo Sidoni,4 Vito Franco,5 Giovanni Tuccari1 1Department of Human Pathology Gaetano Barresi, Section of Anatomic Pathology, University of Messina, Messina, 2Department GF Ingrassia, Section of Anatomic Pathology, University of Catania, Catania, 3Department of Medicine and Surgery, University of Salerno, Salerno, 4Institute of Pathologic Anatomy and Histology, Division of Cancer Research, University of Perugia, Perugia, 5Department of Human Pathology, Section of Anatomic Pathology, University of Palermo, Palermo, Italy Background: Human epiderma…

Pathologymedicine.medical_specialtysynchronous lymph nodeslcsh:RC254-282OncoTargets and TherapyBreast cancer Human epidermal growth factor receptor 2 Metastases Prognosis Synchronous lymph nodesText miningBreast cancerbreast cancermedicinebreast cancer; human epidermal growth factor receptor 2; metastases; prognosis; synchronous lymph nodesPharmacology (medical)metastasesskin and connective tissue diseasesneoplasmsLymph nodeHuman Epidermal Growth Factor Receptor 2Original Researchbusiness.industryhuman epidermal growth factor receptor 2; breast cancer; synchronous lymph nodes; metastases; prognosishuman epidermal growth factor receptor 2lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensmedicine.diseasemedicine.anatomical_structureOncologysynchronous lymph nodemetastaseprognosisbusinessBreast carcinoma
researchProduct

Optimizing diagnostic algorithms to advance Hepatitis C elimination in Italy: A cost effectiveness evaluation

2021

Objectives: Optimized diagnostic algorithms to detect active infections are crucial to achieving HCV elimination. We evaluated the cost effectiveness and sustainability of different algorithms for HCV active infection diagnosis, in a context of a high endemic country for HCV infection. Methods: A Markov disease progression model, simulating six diagnostic algorithms in the birth cohort 1969‐1989 over a 10‐year horizon from a healthcare perspective was used. Conventionally diagnosis of active HCV infection is through detection of antibodies (HCV‐Ab) detection followed by HCV‐RNA or HCV core antigen (HCV‐Ag) confirmatory testing either on a second sample or by same sample reflex testing. The …

Pediatricsmedicine.medical_specialtyCost effectivenessCost-Benefit Analysiscost-effectiveneContext (language use)HepacivirusAntiviral AgentsLiver diseaseMedicineHumansbusinesshealth care economics and organizationsHepatologybusiness.industryscreeningDisease progressionHCV chronic infectionvirus diseasesDiagnostic algorithmshealthHepatitis CHepatitis C Chronicmedicine.diseaseHepatitis CHcv eliminationdigestive system diseasesWHO targetHcv core antigenbusinessAlgorithms
researchProduct

Expertise

2017

Several sets of guidelines have been published recently and more are in the works. The very recent American College of Physicians/American Academy of Family Practitioners guidelines were put together by a set of authors and consultants without any expertise in the topic under discussion, that is, hypertension. Although we are not maintaining that all guidelines should be written exclusively by experts, complete lack of expertise among guideline authors is not acceptable. ispartof: Journal Of Hypertension vol:35 issue:8 pages:1564-1566 ispartof: location:Netherlands status: published

Pediatricsmedicine.medical_specialtyhypertensionPhysiologySine qua nonAlternative medicineMEDLINE030204 cardiovascular system & hematology1102 Cardiovascular Medicine And Haematology03 medical and health sciencesProfessional Competence0302 clinical medicineInternal MedicinemedicineHumansBLOOD-PRESSURE TARGETSguidelines030212 general & internal medicineSet (psychology)Societies MedicalMETAANALYSISANGIO-EDEMAOLDERMedical educationScience & Technologybusiness.industry1103 Clinical SciencesAGED 60 YEARSGuidelineProfessional competence3. Good healthPeripheral Vascular DiseaseCardiovascular System & HematologyPractice Guidelines as TopicCardiovascular System & CardiologyexpertiseINHIBITORSCardiology and Cardiovascular MedicinebusinessLife Sciences & BiomedicineguidelineANGIO-EDEMAJournal of Hypertension
researchProduct

Applying system dynamics modeling to foster a cause-and-effect perspective in dealing with behavioral distortions associated with a city's performanc…

2015

This paper aims to show how applying system dynamics methodology to performance management can provide a powerful modeling perspective enabling public sector organizations to prevent, detect, and counteract behavioral distortions associated with performance measurement. A dynamic performance management approach is able to support performance management system designers in outlining and implementing a consistent set of measures that can allow public sector decision-makers to pursue sustainable organizational learning and development. This perspective implies a major shift from a static to a dynamic picture of organizational processes and results. It means framing delays between causes and ef…

Performance managementPerformanceStatSettore SECS-P/07 - Economia AziendalePerformance measurementBehavioral distortions of performance measurementCompStatPerformance Management Performance measurement Behavioral distortions of performance measurement Municipal performance Crime Control Compstat.Municipal performancePerformance target
researchProduct

Death receptors as targets in cancer

2013

Anti-tumour therapies based on the use PARAs (pro-apoptotic receptor agonists), including TRAIL (TNF-Related Apoptosis inducing Ligand) or monoclonal antibodies targeting TRAIL-R1 or TRAIL-R2, have been disappointing so far, despite clear evidence of clinical activity and lack of adverse events for the vast majority of these compounds, whether combined or not with conventional or targeted anti-cancer therapies. This brief review aims at discussing the possible reasons for the lack of apparent success of these therapeutic approaches and at providing hints in order to rationally design optimal protocols based on our current understanding of TRAIL signalling regulation or resistance for future…

Pharmacology0303 health sciencesTumor targetingmedicine.drug_classCancerTNF-Related Apoptosis-Inducing LigandBiologyMonoclonal antibodyApoptosis Regulatory ProteinsBioinformaticsmedicine.disease3. Good healthClinical trial03 medical and health sciences0302 clinical medicine030220 oncology & carcinogenesisImmunologymedicineDeath ReceptorsAdverse effect030304 developmental biologyBritish Journal of Pharmacology
researchProduct